about
Effect of inhaler design variables on paediatric use of dry powder inhalersRecent advances in capsule-based dry powder inhaler technology.Investigation into alternative sugars as potential carriers for dry powder formulation of budesonideA safety evaluation of DAS181, a sialidase fusion protein, in rodents.Concurrent oral and inhalation drug delivery using a dual formulation system: the use of oral theophylline carrier with combined inhalable budesonide and terbutaline.Can Patients with Parkinson's Disease Use Dry Powder Inhalers during Off Periods?Towards screening of inhalation formulations: measuring interactions with atomic force microscopy.Design of fine particles for pulmonary drug delivery.New treatments for chronic obstructive pulmonary disease and viable formulation/device options for inhalation therapy.The History of Therapeutic Aerosols: A Chronological Review.The unusual symmetric reopening effect induced by pulmonary surfactant.Customizing inhaled therapy to meet the needs of COPD patients.Ultrasonic nebulization platforms for pulmonary drug delivery.Single-use disposable dry powder inhalers for pulmonary drug delivery.The role of the solid state and physical properties of the carrier in adhesive mixtures for lung delivery.Dry powder inhalation: past, present and future.Inhaled drug therapy development for the treatment of migraine.Routine Use of Budesonide/Formoterol Fixed Dose Combination in Elderly Asthmatic Patients: Practical Considerations.Enabling practical surface acoustic wave nebulizer drug delivery via amplitude modulation.Antisolvent vapor precipitation: the future of pulmonary drug delivery particle production?Preparation and In-vitro Evaluation of Rifampin-loaded Mesoporous Silica Nanoaggregates by an Experimental DesignDrug Delivery Devices for Inhaled Medicines.Development of Budesonide Loaded Biopolymer Based Dry Powder Inhaler: Optimization, In Vitro Deposition, and Cytotoxicity Study.Development of Novel Chitosan Microcapsules for Pulmonary Delivery of Dapsone: Characterization, Aerosol Performance, and In Vivo Toxicity Evaluation.Characterization of a cyclosporine solid dispersion for inhalation.Quorum-quenching acylase reduces the virulence of Pseudomonas aeruginosa in a Caenorhabditis elegans infection model.Effects of device and formulation on in vitro performance of dry powder inhalers.Peak inspiratory flow rate measurement by using In-Check DIAL for the different inhaler devices in elderly with obstructive airway diseases.Nanoparticle deposition onto biofilms.Optimization of the fine particle fraction of a lyophilized lysozyme formulation for dry powder inhalation.Pulmonary delivery of nanosized alendronate for decorporation of inhaled heavy metals: formulation development, characterization and gamma scintigraphic evaluation.Computer-aided design of dry powder inhalers using computational fluid dynamics to assess performance.Device factors affecting pulmonary delivery of dry powders.Developments in the formulation and delivery of spray dried vaccines.Physico-Chemical Properties, Aerosolization and Dissolution of Co-Spray Dried Azithromycin Particles with L-Leucine for Inhalation.Guiding Inspiratory Flow: Development of the In-Check DIAL G16, a Tool for Improving Inhaler Technique.CFD simulation of aerosol delivery to a human lung via surface acoustic wave nebulization.Formulation of novel dry powder inhalation for fluticasone propionate and salmeterol xinafoate with capsule-based device.Pulmonary Safety and Tolerability of Inhaled Levodopa (CVT-301) Administered to Patients with Parkinson's Disease.Multi-scale modelling of powder dispersion in a carrier-based inhalation system.
P2860
Q27324278-70AEF5AB-6134-452D-BFD5-391A323D6722Q33711473-E355445A-62E4-4E8C-B622-57E6AC4C0751Q34725260-044FC8AE-245A-4D9D-93A9-078653AE48AFQ35161415-B7B90464-F12D-4C43-B74E-E9198C51F970Q35580773-B767D055-2588-4478-B648-F2395E0D0586Q35691050-F0222FAF-CC48-4242-B7CD-98EDDF730140Q36316852-BC1DC34B-3555-4759-BF32-FE1AC7E1CE74Q36815946-3B069CE3-2ECC-4D2E-AAAC-DB3F8387AADEQ37532557-A87631FE-A76E-41ED-A912-F406CE7CA318Q37613123-117CF1AE-83CB-4B60-BBA7-C9E22465B266Q37629643-F6C43077-2CA6-4FF9-8FB6-0966C292B913Q37702735-935A27D8-2EDC-4045-AA49-DAC7FB14C983Q37748786-DAF76BB4-BC45-49E6-B4E1-4381BC281A78Q37809879-232EFA1D-6328-42BE-BE4C-BA10ECC147BFQ38614470-79DA0CF5-EFCF-4876-8DD5-39A84822855DQ38830375-3B079A1C-EE1A-49D5-960D-C184B3178BA7Q38896569-C1AE43F3-4F40-4E8E-8125-8AB21F8AC4B6Q38930261-FF25CDF4-3317-4E31-A666-8B4EDA75D17AQ39208358-308B3DC4-3CA3-4AAD-BF3D-C71457472D3FQ39275512-23C3DDF6-0479-4BE5-9C7A-1B760961AE62Q39785447-76820B71-6889-48BF-B804-25B8244C0CE3Q40464067-E40AF752-742A-465F-B7D8-9C6790A6C771Q41498114-76820959-ABEF-4DDB-B989-89C1D11B7A43Q41503040-06A2635D-3C0A-4649-9D64-61242F749CB5Q42088619-AEC38EEE-0D74-476E-A6C2-FB1B178E1058Q42111522-AF268C64-7FDC-4A3D-945E-41424E901835Q42218975-AED75110-C848-4D1F-97B0-9D2AE4EA8CBFQ42319679-A997E035-3BED-4E64-8545-600E92076A4FQ42414603-D866A457-CB57-4CA9-8649-4FB425CF7CA3Q45250033-A5943A4F-6B25-4B36-8B3F-354B80A0C06EQ45270582-BFADFB9C-5250-42DB-B452-47868080C449Q45849394-004B88D5-9409-4637-A515-768B8CB5EAA3Q46549960-66637408-8EBC-4D83-82D8-DC748BD74EA4Q47106090-C93EB4D4-D6C3-408A-9453-1F3C20A45178Q47646246-8AA17080-59D9-4CDB-844A-F911238D0F2DQ47653263-8BCAF46C-79DE-4533-A92C-62048546A846Q47754949-41888368-89EB-4775-9D52-D619FCEE4D16Q48020453-D124951C-72A7-483C-85C3-5CF9049548B4Q50203307-546D98F5-F3D3-41A9-B82F-B1DAF28CEAD1Q50994018-7E41F93E-4BE7-4AD4-B439-3342A75C2B59
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Dry powder inhalers for pulmonary drug delivery.
@ast
Dry powder inhalers for pulmonary drug delivery.
@en
type
label
Dry powder inhalers for pulmonary drug delivery.
@ast
Dry powder inhalers for pulmonary drug delivery.
@en
prefLabel
Dry powder inhalers for pulmonary drug delivery.
@ast
Dry powder inhalers for pulmonary drug delivery.
@en
P2860
P356
P1476
Dry powder inhalers for pulmonary drug delivery.
@en
P2093
De Boer AH
Frijlink HW
P2860
P356
10.1517/17425247.1.1.67
P407
P577
2004-11-01T00:00:00Z